{"abstract": "An F.D.A. advisory committee will consider placing further limits on the use of the Amgen drugs Epogen and Aranesp and the Johnson & Johnson drug Procrit.", "web_url": "https://www.nytimes.com/2008/03/12/business/12anemia.html", "snippet": "An F.D.A. advisory committee will consider placing further limits on the use of the Amgen drugs Epogen and Aranesp and the Johnson & Johnson drug Procrit.", "lead_paragraph": "With federal drug regulators planning another meeting on Thursday to weigh the safety of widely used anemia drugs, Dr. Athanasius Anagnostou resists any urge to say \u201cI told you so.\u201d ", "print_section": "C", "print_page": "1", "source": "The New York Times", "multimedia": [], "headline": {"main": "Risks of Anemia Drugs for Patients With Cancer to Get More Scrutiny", "kicker": null, "content_kicker": null, "print_headline": "Risks of Anemia Drugs for Patients With Cancer to Get More Scrutiny", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Blood", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson Inc", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 4, "major": "N"}, {"name": "subject", "value": "ANEMIA", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 6, "major": "N"}], "pub_date": "2008-03-12T04:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/3c12b0e1-5855-5936-ab39-4cec51530f87", "word_count": 976, "uri": "nyt://article/3c12b0e1-5855-5936-ab39-4cec51530f87"}